User profiles for N. Lechtzin

Noah Lechtzin

Johns Hopkins University
Verified email at jhmi.edu
Cited by 9033

[HTML][HTML] Current treatment of adult Duchenne muscular dystrophy

KR Wagner, N Lechtzin, DP Judge - Biochimica et Biophysica Acta (BBA) …, 2007 - Elsevier
… Jefferies and colleagues recently reported that in 47 individuals with DMD or BMD there
was a higher incidence of DCM in those with a deletion occurring in exons encoding the N-…

Distraction therapy with nature sights and sounds reduces pain during flexible bronchoscopy: A complementary approach to routine analgesia

GB Diette, N Lechtzin, E Haponik, A Devrotes… - Chest, 2003 - Elsevier
… Compared to patients in the study by Lechtzin et al, 5 those in the present study had similar
… , while 62% reported it in the study by Lechtzin et al. Less healthy patients may metabolize …

Respiratory measures in amyotrophic lateral sclerosis

N Lechtzin, ME Cudkowicz, M de Carvalho… - … Lateral Sclerosis and …, 2018 - Taylor & Francis
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that
causes skeletal muscle weakness, including muscles involved with respiration. Death often …

In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease

SP Patil, JA Krishnan, N Lechtzin… - Archives of internal …, 2003 - jamanetwork.com
Background Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a
frequent cause of hospitalization in the United States. Previous studies of selected populations …

Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis

…, W Checkley, CA Merlo, MW Konstan, N Lechtzin… - Jama, 2010 - jamanetwork.com
… (n = 1712), less than 2 years of observation in the cohort (n = 4971), fewer than 2 cultures in
the first 2 years (n = 3666), or no cultures or FEV 1 measurements during follow-up (n = 476) …

Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment

N Lechtzin, J Rothstein, L Clawson… - … Lateral Sclerosis and …, 2002 - Taylor & Francis
Patients with amyotrophic lateral sclerosis (ALS) invariably develop respiratory muscle
weakness and most die from pulmonary complications. There are numerous tests available to …

Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV1 Decline in Cystic Fibrosis

…, CA Merlo, M Diener-West, N Lechtzin… - American journal of …, 2008 - atsjournals.org
… than 2 years of observation in the cohort (n = 3,529), MRSA in the first 2 years of observation
(n = 2,480), or fewer than two cultures in the first 2 years (n = 3,298). The total number of …

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension

…, T Housten, HC Champion, N Lechtzin… - American journal of …, 2010 - atsjournals.org
… This is consistent with our recent report of a significantly higher resting heart rate and
higher N-terminal prohormone brain natriuretic peptide serum levels in patients with SSc-PAH …

Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections

…, S Ravishankar, ML Aitken, N Lechtzin… - Science translational …, 2018 - science.org
The lack of new antibiotics is among the most critical challenges facing medicine. The problem
is particularly acute for Gram-negative bacteria. An unconventional antibiotic strategy is to …

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension

…, D Boyce, T Housten, N Lechtzin… - European …, 2011 - Eur Respiratory Soc
The aim of this study was to examine the causes and outcomes of hospitalisation in patients
with pulmonary arterial hypertension (PAH). 205 consecutive hospitalisations occurring …